4//SEC Filing
Schamroth Michael 4
Accession 0001062993-19-003631
CIK 0000875622other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 3:41 PM ET
Size
6.4 KB
Accession
0001062993-19-003631
Insider Transaction Report
Form 4
Schamroth Michael
Director
Transactions
- Exercise/Conversion
Common Stock, $0.001 par value
2019-09-03$26.43/sh+15,000$396,450→ 115,890 total - Exercise/Conversion
StoStock Option (right to buy)
2019-09-03−15,000→ 0 totalExercise: $26.43Exp: 2019-09-07→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option vested in full on September 8, 2009.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeother
Related Parties
1- filerCIK 0001375385
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 3:41 PM ET
- Size
- 6.4 KB